BEGIN:VCALENDAR VERSION:2.0 PRODID:-//Cancer Epigenetics Society - ECPv6.18.3//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:Cancer Epigenetics Society X-ORIGINAL-URL:https://ces.b2sg.org X-WR-CALDESC:Events for Cancer Epigenetics Society REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:Europe/Paris BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20150329T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20151025T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20160327T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20161030T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20170326T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20171029T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20180325T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20181028T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20190331T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20191027T010000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;VALUE=DATE:20180210 DTEND;VALUE=DATE:20180215 DTSTAMP:20171001T200958Z CREATED:20170507T162805Z LAST-MODIFIED:20171001T200958Z UID:17852-1518220800-1518652799@ces.b2sg.org SUMMARY:Cancer Epigenetics: New Mechanisms\, New Therapies (B4) in Breckenridge\, CO\, USA DESCRIPTION:Bringing together both the scientific and the pharmaceutical communities\, this Keystone Symposia meeting will will focus on: \n1) The newest findings on the mechanisms by which epigenetic pathways are established and maintained in normal and stem cells\, and how these go awry during aging and cancer\, with a special emphasis on histone modifications\, chromatin remodeling and the unexpected increased number of DNA modifications ((hydroxy)methylcytosine and methyladenine); \n2) The growing roles of noncoding RNAs in cancer and the emergence of the new and exciting realm of RNA epigenetics; \n3) Use of new omics technologies to interrogate altered epigenetic landscapes in tumors and assess their clinical implications; \n4) Novel and promising therapeutic drugs aimed at reversing specific epigenetic alterations. Ultimately\, the meeting will provide great opportunities for senior and junior scientists to meet the leaders in the field from both academia and industry\, hence forging exciting interdisciplinary interactions and creating potential new collaborations in the booming area of cancer epigenetics. \nInvited Speakers: \nKaren Adelman\, Harvard Medical School\, USA \nGeneviève Almouzni\, Centre National de la Recherche Scientifique\, France \nStephen B. Baylin\, Johns Hopkins University School of Medicine\, USA \nAznar Benitah\, ICREA and Institute for Research in Biomedicine\, Spain \nShelley L. Berger\, University of Pennsylvania\, USA \nJames E. Bradner\, Novartis Institutes for BioMedical Research\, USA \nAnne Brunet\, Stanford University\, USA \nHoward Y. Chang\, Stanford University\, USA \nMark A. Dawson\, Peter MacCallum Cancer Centre\, Australia \nLuciano Di Croce\, Centre for Genomic Regulation\, Spain \nMichaela Frye\, University of Cambridge\, UK \nFrançois Fuks\, Université Libre De Bruxelles\, Belgium \nChuan He\, University of Chicago\, USA \nPeter A. Jones\, Van Andel Research Institute\, USA \nCigall Kadoch\, Dana-Farber Cancer Institute\, Harvard Medical School\, USA \nTony Kauzarides\, University of Cambridge\, UK \nElectron Kebebew\, National Cancer Institute\, USA \nRobert E. Kingston\, Massachusetts General Hospital\, USA \nRobert MacLeod\, Ionis Pharmaceuticals\, Inc.\, USA \nChris Marine\, VIB\, Belgium \nRobert A. Martienssen\, Cold Spring Harbor Laboratory\, USA \nRonan C. O’Hagan\, Merck Research Laboratories\, USA \nKornelia Polyak\, Dana-Farber Cancer Institute\, Harvard Medical School\, USA \nRab K. Prinjha\, GlaxoSmithKline\, UK \nGideon Rechavi\, Tel Aviv University\, Israel \nDanny F. Reinberg\, HHMI/New York University\, USA \nAli Shilatifard\, Northwestern University\, USA \n  \nDeadlines: \nScholarship Deadline: Oct 10\, 2017 \n Discounted Abstract Deadline: Oct 10\, 2017 \n Abstract Deadline: Nov 8\, 2017 \n Discounted Registration Deadline: Dec 12\, 2017  \nScientific Organizers: François Fuks and Anne Brunet\n  URL:https://ces.b2sg.org/event/keystone-feb2018/ LOCATION:Beaver Run Resort\, 620 Village Rd\, Breckenridge\, CO\, 80424\, United States CATEGORIES:Meetings ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/keystone-e1494159273833.jpg END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20180121 DTEND;VALUE=DATE:20180126 DTSTAMP:20171001T201442Z CREATED:20170508T194630Z LAST-MODIFIED:20171001T201442Z UID:17903-1516492800-1516924799@ces.b2sg.org SUMMARY:DNA and RNA Methylation (A7) in Vancouver\, Canada DESCRIPTION:The meeting will begin on Sunday\, January 21 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday\, January 25 with a closing plenary session from 17:00 to 19:00\, followed by a social hour and entertainment. We recommend return travel on Friday\, January 26 in order to fully experience the meeting. \nSpeakers: \nJuan Alfonzo\, Ohio State University\, USA  \nHoward Y. Chang\, Stanford University\, USA  \nJoseph F. Costello\, University of California\, San Francisco\, USA  \n Dana C. Dolinoy\, University of Michigan School of Public Health\, USA  \nJoseph R. Ecker\, The Salk Institute for Biological Studies\, USA  \n Michaela Frye\, University of Cambridge\, UK  \nFrançois Fuks\, Université Libre De Bruxelles\, Belgium   \nMargaret A. Goodell\, Baylor College of Medicine\, USA  \nChuan He\, University of Chicago\, USA  \nStacy M. Horner\, Duke University Medical Center\, USA  \nSuyun Huang\, MD Anderson Cancer Center\, USA  \nSteven E. Jacobsen\, University of California\, Los Angeles\, USA  \nSamie Jaffrey\, Weill Medical College of Cornell University\, USA  \nPeter A. Jones\, Van Andel Research Institute\, USA \nAlexander Meissner\, Harvard University\, Broad Institute\, USA  \nYunsun Nam\, University of Texas Southwestern Medical Center\, USA  \nTao Pan\, University of Chicago\, USA  \nTariq M. Rana\, University of California\, San Diego\, USA  \nAnjana Rao\, La Jolla Institute for Allergy and Immunology\, USA  \nGideon Rechavi\, Tel Aviv University\, Israel  \nWolf Reik\, Babraham Institute\, UK \nDirk Schübeler\, Friedrich Miescher Institute for Biomedical Research\, Switzerland  \nYang Shi\, Children’s Hospital Boston\, Harvard Medical School\, USA  \nYanhong Shi\, Beckman Research Institute of City of Hope\, USA  \nChunxiao Song\, University of Oxford\, UK  \nSohail F. Tavazoie\, Rockefeller University\, USA  \nTing Wang\, Washington University\, USA  \nAndrew Xiao\, Yale University\, USA  \n  \nDeadlines: \nScholarship Deadline: Sep 27\, 2017\n Discounted Abstract Deadline: Sep 27\, 2017 \n Abstract Deadline: Oct 27\, 2017\n Discounted Registration Deadline: Nov 28\, 2017  URL:https://ces.b2sg.org/event/keystone-jan2018/ LOCATION:Fairmont Hotel Vancouver\, 900 W Georgia St\, Vancouver\, V6C 2W6\, Canada CATEGORIES:Meetings ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/keystone-e1494159273833.jpg END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20171221 DTEND;VALUE=DATE:20171223 DTSTAMP:20171001T202217Z CREATED:20151230T052828Z LAST-MODIFIED:20171001T202217Z UID:12213-1513814400-1513987199@ces.b2sg.org SUMMARY:19th International Conference on Epigenetics\, Chromatin and Transcription in Isanbul\, Turkey DESCRIPTION:The ICECT 2017: 19th International Conference on Epigenetics\, Chromatin and Transcription aims to bring together leading academic scientists\, researchers and research scholars to exchange and share their experiences and research results about all aspects of Epigenetics\, Chromatin and Transcription. It also provides the premier interdisciplinary forum for researchers\, practitioners and educators to present and discuss the most recent innovations\, trends\, and concerns\, practical challenges encountered and the solutions adopted in the field of Epigenetics\, Chromatin and Transcription. \nImportant dates \nAbstracts/Full-Text Paper Submission Deadline: May 26\, 2017 \nNotification of Acceptance/Rejection: June 30\, 2017 \nFinal Paper (Camera Ready) Submission & Early Bird Registration Deadline: November 21\, 2017 URL:https://ces.b2sg.org/event/icect-dec2017/ LOCATION:The President Hotel\, Tiyatro Cad. No. 25 Beyazit\, Istanbul\, 34126\, Turkey CATEGORIES:Meetings ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2015/12/waste.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20171106 DTEND;VALUE=DATE:20171109 DTSTAMP:20171001T201536Z CREATED:20170509T201255Z LAST-MODIFIED:20171001T201536Z UID:17934-1509926400-1510185599@ces.b2sg.org SUMMARY:2nd International Congress on Epigenetics & Chromatin in Frankfurt\, Germany DESCRIPTION:2nd International Congress on Epigenetics & Chromatin\n CME | CPD Accredited\n November 06-08\, 2017\n Frankfurt\, Germany \n  \nWe invite all the participants and attendees  from all over the world to attend 2nd International Congress on Epigenetics and Chromatin 2017 during November 06 – 08\, 2017 at Frankfurt\, Germany with the Theme: Revolutionary Strategies in Diagnosis and Treatment of Cancer and Genetic Disorders which includes prompt Keynote Presentations\, Oral talks\, Poster Presentations\, Workshop\, Symposia and Exhibitions. \nThe important target of this congress is to give a worldwide gathering to front line research in Genetic Disorders\, Epigenetics and Cancer Sciences. \nThis meeting gives “the focal hub” for individuals to exhibit their exploration and trade thoughts in a European venue. The sorting out group gathers top speakers covering the most recent advances in the field\, fusing assorted qualities in each sense. \nThe overarching goal of this conference series is to cover chromatin regulation\, chromatin dynamics\, signaling to chromatin\, nuclear architecture and dynamics\, developmental epigenetics\, cancer epigenetics\, epigenomics\, epigenetics and human diseases\, genome stability\, environmental epigenetics\, and Tran’s generational inheritance. \n  \nCALL FOR PRESENTERS: Debut your latest innovations at Epigenetics 2017 Congress\, our Organizing Committee anticipates over 300 participants to attend this premier event. \nExhibiting at this event will attain you with an exceptional format in showcasing your products and services. \n  \nFor Queries: \nContact: Lucy Watson \nDirect: (702) 508-5200 Ext: 8033 \nCustomer Service: +1(800) 216 6499 \nDrop us an email for Program enquiry: epigenetics@conferenceseries.net \nConference website: http://epigenetics.conferenceseries.com   URL:https://ces.b2sg.org/event/2nd-intl-congress-nov2017/ LOCATION:H4 Hotel Frankfurt Messe\, Oeserstraße 180\, Frankfurt\, 65933\, Germany CATEGORIES:Meetings ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/05/Epigenetics_conference-1-e1494350047986.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20171026 DTEND;VALUE=DATE:20171029 DTSTAMP:20171001T201816Z CREATED:20170708T200059Z LAST-MODIFIED:20171001T201816Z UID:18615-1508976000-1509235199@ces.b2sg.org SUMMARY:International Conference on Cancer Genetics and Epigenetics in Osaka\, Japan DESCRIPTION:About the Conference \nEpigenetics and Cancer 2017 is delighted to announce the International Conference on Cancer Genetics & Epigenetics which will be held  between  October 26-28\, 2017 at Osaka\, Japan. It is our pleasure to welcome you to take part  in this conference. This gathering at Osaka\, Japan will continue for three days which includes prompt  Keynote Presentations\, Poster Presentations\, E-poster\, Oral talks\, Symposia\, Workshop\, Scientific meetings and Exhibitions. \nEpigenetics and Cancer 2017 is organized with the theme “From Novel therapies to Revolutionary Strategies \, Diagnosis and Treatment”. This conference is comprised of many interactive sessions related to Cancer Genetics and Epigenetics which comprises a broad range from novel advancements to various strategies for diagnosis and treatment. \nGoal of the conference \nThe central goal of this conference  is to give a universal discussion for cutting edge research and inquire about Cancer Genetics and Epigenetics. This gathering gives “the central  point” for individuals to introduce their examination and research thoughts. Purpose of this event is to strengthen new perspectives for treatment that will be significant over the scope of Epigenetics and Cancer. \nWhy attend? \nEpigenetics and Cancer 2017  Conference is a novel discussion to unite overall recognized scholastic in the field of Genetics\, Genomics and Proteomics Researchers\, Public well-being experts\, Scientists\, Academic researchers\, Industry specialists\, Scholars to exchange about state of the Research and Development. The arranging group assembles eminent speakers covering the most recent advances in the field\, fusing differing qualities in each sense. We like wise incorporate talks on most recent methodologies for concentrating these biological inquiries. We encourage multidisciplinary approach as well. A Unique Opportunity for Advertisers and Sponsors at this International event. \nFor Cancer Epigenetics Society Members \nThe Cancer Epigenetics Society is part of the Organizing Committee for this meeting. Our Members receive a 15% discount on registration fees. Please contact us here to claim the discount. URL:https://ces.b2sg.org/event/epigenetics-and-cancer-2017/ LOCATION:Conferenceseries\, Osaka\, Japan CATEGORIES:Meetings ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/07/osaka-conf-1.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20171025 DTEND;VALUE=DATE:20171027 DTSTAMP:20171001T202044Z CREATED:20170508T153335Z LAST-MODIFIED:20171001T202044Z UID:17897-1508889600-1509062399@ces.b2sg.org SUMMARY:Epigenetic Mechanisms in Health and Disease in Barcelona\, Spain DESCRIPTION:“Epigenetic mechanisms in health and disease” is the last of a series of Barcelona Conferences on Epigenetics and Cancer (BCEC). The 2017 edition is co-organized by B·Debate\, an initiative of Biocat and “la Caixa” Foundation\, and the Molecular Biology Institute of Barcelona (IBMB-CSIC)\, together with Josep Carreras Leukemia Research Institute (IJC). The scientific program has been put together by Albert Jordan\, Ferran Azorin\, Marian Martínez-Balbas\, Jordi Bernuès and Marcus Buschbeck. \nThe aim of the BCEC 2017 is to bring together young and established scientists in an interdisciplinary forum to review the progress made in the field of epigenetics. Presentations will highlight the translation of basic research into clinical applications and discuss still unexploited fundamental insights. We will cover topics including stem cell biology\, development\, leukemia and nuclear organization. \nSpeakers: \nCarl Wu \, Johns Hopkins University School of Medicine\, USA\n Marian Martínez-Balbas \, IBMB-CSIC\, Barcelona\n Susan Gasser\, Friedrich Miescher Institute\, Switzerland\n Ferran Azorin\, IBMB-CSIC\, Barcelona\n Genevieve Almouzni\, Institut Curie / CNRS\, France\n Wendy Bickmore\, University of Edinburg\, UK\n Ari Melnick\, Weill Cormel Medical College\, USA\n Sylvia Erhardt\, University of Heidelberg\, Germany\n Amos Tanay\, The Weizmann Institute\, Israel\n Henk Stunnenberg\, The Radboud University Medical Centre\, The Netherlands\n Manel Esteller\, PEBC-IDIBELL\, Barcelona\n Florian Heidel\, Jena University Hospital\, Germany \nParticipants will further have access to the 2nd PMPPC symposium celebrated on the afternoon of October 26. Confirmed speakers include: \nVictor Corces\, Emory University\, USA\n Carlo M. Croce\, Ohio State University\, USA\n Jose-Luis Gómez-Skarmeta\, CABD\, Sevilla\n Alain Balmain\, CUCSF\, USA \nMore information will be available soon. \nSubmit your abstract until September 15!\n Registration is already OPEN and the fee of 80 Euros will cover participation and catering. URL:https://ces.b2sg.org/event/bdabate-barcelona-oct2017/ LOCATION:CosmoCaixa Barcelona\, Carrer d'Isaac Newton 26\, Barcelona\, 08022 \, Spain CATEGORIES:Meetings ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/bdebate_400x400-e1494251670611.jpg END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20171012 DTEND;VALUE=DATE:20171014 DTSTAMP:20171001T200750Z CREATED:20170507T230546Z LAST-MODIFIED:20171001T200750Z UID:17891-1507766400-1507939199@ces.b2sg.org SUMMARY:3rd Annual Epigenetics Discovery Congress in London\, UK DESCRIPTION:After our two successful editions\, we are glad to announce the 3rd Annual Epigenetics Discovery Congress. \nWith a tremendous progress in technology to generate and analyze reference epigenomes\, the epigenetics field is fetching a lot of importance and attention across all medical science’s areas.  Additionally\, novel epigenetic molecules across many target classes for drug discovery\, have been the prime focus of the pharmaceutical industry. \nTo meet and support this pace of the epigenetics research and development field\, the 3rd Annual Epigenetics Discovery Congress will present novel research and address challenges right from molecular sciences & disease diagnosis to drug discovery streams. The congress will also be a great platform to learn about novel technologies like next generation sequencing and single cell analysis. \nSpeakers: \nPaola Arimondo\, ETaC\, France \nRoland Baumgartner\, 4SC\, Germany  \nCarlos Buesa\, Oryzon\, Spain \nSusan Clark\, Garvan Institute of Medical Research\, Sydney\, Australia \nJerome Dejardin\, MSH\, France \nJames Flanagan\, Imperial College London\, UK \nPetra Hajkova\, MRC Institute of Medical Sciences (LMS)\, UK \nJohn Holloway\, University of Southampton\, UK \nKilian Huber\, University of Oxford\, UK \nPaul Hurd\, Queen Mary University of London\, UK \nKaren Lillycrop\, University of Southampton\, UK \nGavin Kelsey\, The Babraham Institute\, UK \nGuro Lind\, University of Oslo\, Norway \nJelena Mann\, Newcastle University\, UK \nRab Prinjha\, GlaxoSmithKline\, UK \nJoëlle Rüegg\, Karolinska Institutet\, Sweden \nChristopher Schofield\, University of Oxford\, UK \nPaul Shiels\, University of Glasgow\, UK \nJesse Smith\, Epizyme\, USA \nRémi Terranova\, Novartis Institutes for BioMedical Research\, Switzerland \nMaria Toledo\, University of Nottingham\, United Kingdom \nJonathan Turner\, Luxembourg Institute of Health\, Luxembourg \nKatherine West\, University of Glasgow\, UK \nDavid M. Wilson\, Astrazeneca\, UK \n  \n  \n  URL:https://ces.b2sg.org/event/3rd-epigenetics-congress-oct2017/ LOCATION:TBA\, London\, United Kingdom CATEGORIES:Meetings ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/epigenetics-discovery-congress.jpeg END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20170828 DTEND;VALUE=DATE:20170831 DTSTAMP:20170509T085903Z CREATED:20170507T222515Z LAST-MODIFIED:20170509T085903Z UID:17886-1503878400-1504137599@ces.b2sg.org SUMMARY:Transgenerational Epigenetic Inheritance: Impact for Biology and Society DESCRIPTION:The conference will combine presentations from leaders in the field of epigenetics and epigenetic inheritance related to behavior\, metabolism and physiology in humans and animal models\, from mental health and epidemiology to bioinformatics and ethics. It will address the question of how epigenetic processes mediate the impact of experiences across one or multiple generations.  Germline and non-germline modes of transmission and challenges for DNA methylation\, chromatin modifications and ncRNAs as mechanisms of epigenetic inheritance will be discussed. The inherent difficulties of this challenging discipline and the innovative approaches that can address these difficulties will be critically discussed. The program includes lectures\, short presentations and poster sessions. It also includes a public lecture (in German) discussing how epigenetics can change our view on health. This public lecture is open to everyone (academics\, journalists and any citizen). \nSpeakers:  \nMarisa Bartolomei\, University of Pennsylvania\, USA \nStefan Beck\, University College London\, UK \nChristoph Bock\, University of Vienna\, AT \nLiran Carmel\, Hebrew University of Jerusalem\, IL \nKatharina Gapp\, Sanger Institute\, Cambridge\, UK \nJohannes Graeff\, Ecole Polytechnique Fédérale\, Lausanne\, CH \nCarlos Guerrero-Bosagna\, Linköping University\, SE \nLeah Houri-Ze’evi\, Tel Aviv University\, IL \nEva Jablonka\, Tel Aviv University\, IL \nJosep Jiménez-Chillarón\, Hospital Sant Joan de Deu\, Barcelona\, SP \nMaurizio Meloni\, University of Sheffield\, UK \nEric Miska\, University of Cambridge\, UK \nRuth Müller\, Technical University Munich\, DE \nMarcus Pembrey\, University College London\, UK \nVardhman Rakyan\, Blizard Institute\, London\, UK \nMinoo Rassoulzadegan\, University of Nice\, FR \nAbhay Sharma\, Dehli University Campus\, IN \nMichael Skinner\, Washington State University\, USA \nAdelheid Soubry\, Catholic University Leuven\, BE \nPeter Spork\, Wissenschaftsautor\, Hamburg\, DE \nMoshe Szyf\, McGill University\, Montreal\, CA \nJorg Tost\, Commissariat à l’Energie Atomique\, Evry\, FR \nErica Watson\, University of Cambridge\, UK \nRachel Yehuda\, Mount Sinai Hospital\, New York\, USA \nThe symposium will be held in the historic main building of ETHZ\, talks and the public lecture in the Auditorium Maximum\, Room 30\, Floor F\, and poster sessions in the aula outside the auditorium. URL:https://ces.b2sg.org/event/latsis-symposium2017/ LOCATION:ETHZ Swiss Federal Institute of Technology Zurich\, Rämistrasse 101\, Zurich\, Switzerland CATEGORIES:Meetings ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/eth-1.jpg END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20170824 DTEND;VALUE=DATE:20170825 DTSTAMP:20170507T221028Z CREATED:20170507T215846Z LAST-MODIFIED:20170507T221028Z UID:17880-1503532800-1503619199@ces.b2sg.org SUMMARY:3rd Epigenetic Methyltransferases - Structure\, Mechanism and Inhibition DESCRIPTION:Speakers: \nRima Al-awar\, Pharmacology & Toxicology\, University of Toronto and Ontario Institute for Cancer Research (OICR)\, Canada. \nMichael Cosgrove\, Biochemistry and Molecular Biology\, State University of New York Upstate Medical University\, USA \nJocelyn Côté\, Cellular and Molecular Medicine\, University of Ottawa\, Canada\n \nJean-François Couture\, Biochemistry\, Microbiology and Immunology\,\n University of Ottawa\, Canada \nPaul Delgado-Olguín\, Physiology and Experimental Medicine\, The Hospital for Sick Children\, Toronto\, Canada. \nBenjamin Garcia\, Biochemistry and Biophysics\, University of Pennsylvania School of Medicine. USA \nJean-Claude Guillemot\, AFMB Polytech\, Marseille\, France \nIngo Hartung\, Drug Discovery\, Pharmaceuticals\, Bayer\, Germany \nMathieu Lupien\, Medical Biophysics\,University of Toronto\, Canada \nDafydd Owen\, Pfizer\, USA \nMasoud Vedadi\, Pharmacology and Toxicology\, and SGC University of Toronto  \nShaomeng Wang\, Pharmacology and Medicinal Chemistry\,\n University of Michigan\, USA \nKehao Zhao\, Novartis\, USA \n  \nOrganizing committee: Cheryl Arrowsmith\, Santha Santhakumar\, Masoud Vedadi URL:https://ces.b2sg.org/event/3rd-epigenetic-methyltransferases-aug2017/ LOCATION:Chestnut Residence & Conference Centre\, 89 Chestnut St\, Toronto\, Ontario\, M5G 1R\, Canada CATEGORIES:Meetings ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/sgc-big.jpg END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20170730 DTEND;VALUE=DATE:20170805 DTSTAMP:20170509T085546Z CREATED:20170507T213644Z LAST-MODIFIED:20170509T085546Z UID:17878-1501372800-1501891199@ces.b2sg.org SUMMARY:Epigenetics in Action: From Mechanisms to Biological Impacts DESCRIPTION:This meeting takes place in a relaxed environment with outstanding scientists at all post-undergraduate stages. In this informal atmosphere\, discussions begin over breakfast\, continue during the afternoon and extend into the evening through convivial gatherings after each session. Early career scientists and students will have the occasion to discuss their unpublished data with distinguished leaders throughout the conference\, and will have the opportunity to present their work in dedicated slots throughout the program. \nFor the second time the conference will incorporate a Gordon Research Seminar as a specific means to foster involvement by scientists at the graduate student and post doctoral level. Planned by and for trainees\, it will provide an opportunity for our junior researchers to present seminars and posters in a supportive\, interactive environment. \nSpeakers: \nBradley Bernstein\, Harvard University\, USA \nWendy Bickmore\, MRC Human Genetics Unit\, United Kingdom \nXin Chen\, Johns Hopkins University\, USA \nVincent Colot\, Institut de Biologie de l’Ecole Normale Supérieure\, France \nCaroline Dean\, John Innes Centre\, United Kingdom \nJohn Denu\, University of Wisconsin-Madison\, USA \nInes Drinnenberg\, Institut Curie\, France \nSylvia Erhardt\, ZMBH\, Universität Heidelberg\, Germany \nAnne Ferguson-Smith\, University of Cambridge\, United Kingdom \nSusan Gasser\, Friedrich Miescher Institute for Biomedical Research\, Switzerland \nCharles Gersbach\, Duke University\, USA \nDavid Gilbert\, Florida State University\, USA \nJohn Greally\, Albert Einstein College of Medicine\, USA \nShiv Grewal National Institutes of Health\, USA \nAnja Groth\, Biotech Research and Innovation Centre (BRIC)\, University of Copenhagen\, Denmark \nEdith Heard\, Institut Curie\, France \nSteven Jacobsen\, University of California\, Los Angeles / Howard Hughes Medical Institute\, USA \nBenjamin Loppin\, Laboratoire de Biométrie et Biologie Évolutive\, University of Lyon\, France \nKeith Maggert\, University of Arizona\, USA \nHarmit Malik\, Fred Hutchinson Cancer Research Center\, USA \nRobert Martienssen\, Cold Spring Harbor Laboratory\, USA \nMarie Mirouze\, Institut de Recherche pour le Développement (IRD)\, France \nErik Miska\, University of Cambridge\, United Kingdom \nJuerg Mueller\, Max Planck Institute of Biochemistry\, Germany \nVardhman Rakyan\, Blizard Institute\, United Kingdom \nJohn Rinn\, Harvard University\, USA \nSusan Strome\, University of California\, Santa Cruz\, USA \nAzim Surani\, University of Cambridge\, United Kingdom \nMaria-Elena Torres-Padilla\, Institute of Epigenetics and Stem Cells\, Helmholtz Zentrum München\, Germany \nTing Wu\, Harvard Medical School\, USA \nThis GRC will be held in conjunction with the “Epigenetics” Gordon Research Seminar (GRS). Those interested in attending both meetings must submit an application for the GRS in addition to an application for the GRC. Refer to the associated GRS program page for more information. URL:https://ces.b2sg.org/event/epigenetics-in-action-jul2017/ LOCATION:Holderness School\, 33 Chapel Ln\, Holderness\, NH\, 03245\, United States CATEGORIES:Meetings ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2015/12/GRC.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20170626 DTEND;VALUE=DATE:20170629 DTSTAMP:20170507T232143Z CREATED:20170507T210722Z LAST-MODIFIED:20170507T232143Z UID:17875-1498435200-1498694399@ces.b2sg.org SUMMARY:Epigenetic regulatory pathways DESCRIPTION:Join Sung Hee Baek and Tony Kouzarides for this 2.5 day conference in Seoul.  This meeting is inviting abstracts for talk and poster presentation. \nThe topics include: \n\nBiological characterisation of histone and DNA and RNA modification pathways\nThe involvement of epigetic pathways in disease\nThe development of inhibitors and potential drugs against epigenetic pathways\nThe role of chromatin transgenerational inheritance\nChromatin proteins and complexes regulating transcriptional events\nRole of non-coding RNAs in the control of chromatin functions  \n\nChIP Troubleshooting added session\nThose attending the conference are invited to participate in an optional ChIP workshop. Abcam’s Scientific Support Specialists will be on site Tuesday June 27th from 1-2pm with a Troubleshooting presentation and Q&A session. \nRSVP for the workshop here. \n  \nResearch topic Networking lunches\nParticipate in a networking lunch with researchers working on similar pathways and research topics.  Attendees have the option to reserve a seat at one of 6 designated Tables to encourage collaboration and discussion. \nLunch time table topics include: \n\nDrug discovery and targeting epigenetics pathway\nGenome organization and architecture\nCancer epigenetic\nStem cell epigenetics\nDNA and RNA modifications\nNon-coding RNA\n\n  \nSpeakers: \nKaren Adelman\, Harvard University\, US \nShelley Berger\, University of Pennsylvania\, US \nSalvador Aznar Benitah\, Institute for Research in Biomedicine\, Spain \nAnne Brunet\, Stanford University\, US \nLuciano Di Croce\, Centre for Genomic Regulation\, US \nFrancois Fuks\, Université Libre de Bruxelles\, Belgium \nSung Hee Baek\, Seoul National University\, South Korea \nKristian Helin\, University of Copenhagen\, Denmark \nCigall Kadoch\, Dana-Farber Cancer Institute\, US \nTony Kouzarides\, Gurdon Institute\, UK \nRob Martienssen\, Cold Spring Harbor Laboratory\, US \nEric Miska\, Gurdon Institute\, UK \nHuck Hui Ng\, A*Star Genome Institute of Singapore\, Singapore \nPeter Park\, Harvard Medical School\, US \nRab Prinjha\, Epinova Epigenetics DPU at GlaxoSmithKline\, UK \nBing Ren\, University of California\, San Diego\, US \nJae-Seok Roe\, Cold Spring Harbor Laboratory\, US \nAlexey Ruzov\, University of Nottingham\, UK \nAli Shilatifard\, Northwestern University\, US \nJi-Joon Song\, Korea Advanced Institute of Science and Technology\, South Korea \nKou-Juey Wu\, China Medical University\, Taiwan \nYi Zhang\, Harvard Medical School\, US \n  URL:https://ces.b2sg.org/event/epigenetic-reg-pathways-seoul2017/ LOCATION:Millennium Seoul Hilton\, 50\, SOWOL-RO\, JUNG-GU\, Seoul\, 04637\, Korea\, Democratic People's Republic Of CATEGORIES:Meetings ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/abcam1.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20170524 DTEND;VALUE=DATE:20170526 DTSTAMP:20170507T211804Z CREATED:20170507T203705Z LAST-MODIFIED:20170507T211804Z UID:17872-1495584000-1495756799@ces.b2sg.org SUMMARY:Readers\, writers and erasers DESCRIPTION:Satellite meeting organised by Professor A Ganesan\, Professor Marianne Rots\, Dr Paola Arimondo and Dr Akane Kawamura. \nThis is a residential conference\, which allows for increased discussion and networking. \n\nFree to attend\nAdvanced registration essential (please request an invitation)\nCatering and accommodation available to purchase during registration\n\n  \nSpeakers: \nLucia Altucci \nPanagis Filippakopoulos \nA Ganesan \nClarissa Gerhäuser \nCarmen Jerónimo \nManfred Jung \nBozena Kaminska \nAkane Kawamura \nSaulius Klimasauskas \nNathaniel I. Martin \nMaria Tellez-Plaza \nGianluca Sbardella \nJose-Rubén Tormo \n  \nPrior to this meeting\, there will be a related discussion meeting ‘Frontiers in epigenetic chemical biology‘ held at the Royal Society London on 22 – 23 May 2017. \nEnquiries: Contact the Scientific Programmes team URL:https://ces.b2sg.org/event/readers-writers-erasers-may2017/ LOCATION:Kavli Royal Society Centre\, Chicheley Hall\, Newport Pagnell\, Buckinghamshire\, MK16 9JJ\, United Kingdom CATEGORIES:Meetings ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/royal-society-logo-1-e1494170198357.jpg END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20170522 DTEND;VALUE=DATE:20170524 DTSTAMP:20170509T223202Z CREATED:20170507T201002Z LAST-MODIFIED:20170509T223202Z UID:17863-1495411200-1495583999@ces.b2sg.org SUMMARY:Frontiers in epigenetic chemical biology DESCRIPTION:This interdisciplinary meeting will bring together chemists and biologists that are internationally leading in cutting edge areas of epigenetics.   It is intended for researchers in relevant fields. \n\nFree to attend\nLimited places\, advanced registration is essential\nAn optional lunch can be purchased during registration\n\nAn evening poster session and drinks reception will be held following the close of the meeting on Monday 22 May. Whilst the posters are free to view for all registered participants\, the corresponding optional drinks reception is ticketed. Drinks tickets can be purchased during registration. \nSpeakers: \nPaola B. Arimondo \nShankar Balasubramanian FRS \nRobert Brown \nThomas Carell \nGregory Challis \nChun-wa Chung \nRobert Copeland \nA. Ganesan \nMagdalena Koziol \nTamara Maes \nMaria Berdasco Menéndez \nMarianne Rots \nChristopher Schofield FRS \nDaniel Summerer \nMinoru Yoshida \nThis meeting will be followed by a related satellite meeting ‘Readers\, writers and erasers‘ to be held at the Royal Society at Chicheley Hall on 24 – 25 May 2017. \nMeeting papers will be published in a future issue of Philosophical Transactions B. URL:https://ces.b2sg.org/event/frontiers-epigenetic-chem-bio-may2017/ LOCATION:The Royal Society\, London\, 6-9 Carlton House Terrace\, London\, SW1Y 5AG\, United Kingdom CATEGORIES:Meetings ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/royal-society-logo-1-e1494170198357.jpg END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20170306 DTEND;VALUE=DATE:20170308 DTSTAMP:20160908T012217Z CREATED:20160908T010112Z LAST-MODIFIED:20160908T012217Z UID:17388-1488758400-1488931199@ces.b2sg.org SUMMARY:Epigenetics in Drug Discovery DESCRIPTION:SELECTBIO is thrilled to announce the continuation of Epigenetics in Drug Discovery for 2017. \nThe event will form part of the multi-track conference\, Advances in Drug Discovery\, and will run alongside three additional tracks: Antibodies in Drug Discovery\, Academic Drug Discovery and Stem Cells in Drug Discovery. \nAs a multi-track event\, delegates will have unrestricted access to all conference tracks and networking opportunities. Attracting researchers from both academia and industry\, this track will explore the latest opportunities and challenges for epigeneticists looking to discover and develop new molecular entities. Topics to be addressed include\, assays for Methyltranferases and Demethylases\, Bromodomain inhibitor discovery\, indications beyond cancer\, Non-BET Bromodomains and of course updates in Oncology. \nThanks to vast steps forwards in this field\, epigenetic compounds are becoming more and more common in both pre-clinical and clinical drug discovery. If you work in epigenetics research\, you will benefit from the expert knowledge of academic and industry leaders who are pushing the boundaries of drug discovery\, whilst networking with the technology providers who are enabling them to do so. \nThe Cancer Epigenetics Society is a Supporting organization for this meeting\, and our members are eligible for a 20% discount on registration fees. Please contact the Cancer Epigenetics Society at info@ces.b2sg.org to claim the discount. URL:https://ces.b2sg.org/event/epigenetics-in-drug-discovery/ LOCATION:Epigenetics in Drug Discovery\, Wellcome Genome Campus Conference Centre\, Hinxton\, Cambridge\, CB10 1RQ\, United Kingdom CATEGORIES:Meetings ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/09/SelectBio_logo_greybox_RGB.png ORGANIZER;CN="SELECTBIO":MAILTO:registrationhelp@selectbio.com END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20161130 DTEND;VALUE=DATE:20161203 DTSTAMP:20160105T223856Z CREATED:20151230T052431Z LAST-MODIFIED:20160105T223856Z UID:12209-1480464000-1480723199@ces.b2sg.org SUMMARY:4th Max Planck Freiburg Epigenetics Meeting DESCRIPTION:With the 1st Max Planck Freiburg Epigenetics Meeting in 2010\, we celebrated the establishment of the epigenetic focus at our institute and launched a biennial conference series on epigenetics. \nWe are committed to create an exceptional environment for epigenetic research in Freiburg and we would be very happy if you contributed by sharing your exciting data and novel ideas at the 4th international event which will take place from November 30 to December 2\, 2016. A group of high-profile speakers will be assembled\, representing a broad range of topics in the field of chromatin and epigenetics. We look forward to welcoming you in Freiburg. \nThe programme will include invited and selected talks and give ample time for poster presentations. \nPractical information: \nRegistration will be from 1 April 2016 to 31 August 2016. \nNotification of acceptance for the meeting: 30 September 2016. \nDeadline for payment: 15 October 2016 \nThe conference will take place at the Max Planck Institute of Immunobiology and Epigenetics in Freiburg/Germany\, a medieval city nestled between the famous Black Forest and the vineyards of the Kaiserstuhl. URL:https://ces.b2sg.org/event/4th-max-planck-freiburg-epigenetics-meeting/ LOCATION:Unnamed Venue\, Freiburg\, Germany CATEGORIES:Meetings ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2015/12/MaxPlanck.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20161102 DTEND;VALUE=DATE:20161105 DTSTAMP:20160426T203214Z CREATED:20160426T201256Z LAST-MODIFIED:20160426T203214Z UID:15348-1478044800-1478303999@ces.b2sg.org SUMMARY:abcam: Stem Cell and Higher-Order Chromatin Structure conference DESCRIPTION:Present\, learn and collaborate! Present your work and find out the latest news. \nTopics \n\n\n\n\n\n\n\n\n\n\n\n\n\nCoding and non-coding functions of the genome\nChromatin structure in stem cells\nGenome architecture and human disease\n\nDescription \nStem cells have the unique properties of both self renewal and differentiation into various lineages. In the last few years\, chromatin architecture and noncoding RNAs are emerging as major players in both gene regulation and  stem cell differentiation. This conference will cover some of the most recent advances and cutting edge research in the field of chromatin organization\, transcription regulation and stem cell biology. We aim to provide a forum in which interdisciplinary discussions will promote cross-collaboration between experts in these areas. Moreover\, during the meeting\, there will be great opportunities for young scientists to meet the experts in the field. URL:https://ces.b2sg.org/event/abcam-stem-cell-and-higher-order-chromatin-structure-conference/ LOCATION:Taormina Palazzo dei Congressi\, Sicily\, Italy CATEGORIES:Meetings ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/abcam1.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20161101 DTEND;VALUE=DATE:20161105 DTSTAMP:20160426T185017Z CREATED:20160426T184918Z LAST-MODIFIED:20160426T185017Z UID:15333-1477958400-1478303999@ces.b2sg.org SUMMARY:Wellcome Genome Campus: Epigenomics of Common Diseases 2016 DESCRIPTION:The 6th Epigenomics of Common Diseases conference will bring together leading scientists from the fields of epigenomics\, genetics and bioinformatics to discuss the latest developments in this fast-moving area. \nEpigenetic variation plays an important role in disease processes and provides a promising focus for disease prediction\, prevention and treatment. Technological advancements in the past few years have fuelled a dramatic increase in the scale\, breadth and availability of epigenomic reference data. In addition\, novel developments such as single cell analysis and gene editing present exciting new opportunities. Associations between epigenetic variation\, a variety of risk factors and the development of many diseases continue to emerge but causality has\, in many instances\, not yet been established. \nThis meeting will focus on epigenomic studies across of a wide range of common and other diseases including cancer\, and will include approaches from a variety of different disciplines. It will explore technological and methodological developments and provide a forum to present and discuss recent advances in epigenomics of relevance to human disease. URL:https://ces.b2sg.org/event/wellcome-genome-campus-epigenomics-of-common-diseases-2016/ LOCATION:Wellcome Genome Campus\, Hinxton\, Camebridge\, United Kingdom CATEGORIES:Meetings ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/Wellcome-Genome-Campus.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20161019 DTEND;VALUE=DATE:20161022 DTSTAMP:20160426T200648Z CREATED:20160426T200648Z LAST-MODIFIED:20160426T200648Z UID:15345-1476835200-1477094399@ces.b2sg.org SUMMARY:Chromatin\, Replication and Chromosomal Stability 2016 DESCRIPTION:The fourth meeting in the Chromatin Replication series will explore new ideas on the interplay between chromosome organization\, epigenetic inheritance and genome duplication.\n \nTopics \n\n\n\n\n\n\n\n\n\n\n\n\n\n​Mechanisms of DNA replication\nHow to replicate chromosomes\nCell division and epigenetic plasticity\nEpigenome inheritance and reprogramming\n\n\n\n\n\n\n\n\n\n\n\n\n\nThe epigenetic framework guides events like replication\, repair and transcription\, which in turn themselves leave an imprint on chromatin and chromosomal structure. Understanding how modulation of chromatin during replication and repair influence cell fate decisions in normal development and disease represents a major challenge. By bringing together leading scientists in chromatin\, replication\, and epigenetics\, this conference aims to inspire discussions and new ideas on the interplay between chromosome organisation\, epigenetic inheritance and genome duplication. URL:https://ces.b2sg.org/event/chromatin-replication-and-chromosomal-stability-2016/ LOCATION:University of Copenhagen\, Denmark CATEGORIES:Meetings ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/abcam1.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20161005 DTEND;VALUE=DATE:20161009 DTSTAMP:20160625T123750Z CREATED:20151230T051822Z LAST-MODIFIED:20160625T123750Z UID:12207-1475625600-1475971199@ces.b2sg.org SUMMARY:Danube Scientific Conference on Epigenetics DESCRIPTION:In the last couple of years the word epigenetics became used in several meanings. \nThis meeting will try to review the concepts of epigenetics\, the current state of the research in this field and the research methods of the field. Beside this we plan to be a meeting forum for the researchers and clinicians who are studying or planning to study topics in the field of epigenetics. \nWe plan to put forward those topics that deal mainly with the covalent modifications of the chromatin (DNA methylation and histone tail modifications) and their consequences especially those that define the transcriptional possibilities of a cell in a specific chromatin context. \nPlease join us at the meeting! We encourage everybody to submit an abstract. The results can be presented on posters or by talks\, most of which will be selected from the submitted abstracts. URL:https://ces.b2sg.org/event/danube-scientific-conference-on-epigenetics/ LOCATION:Unnamed Venue\, Dudapest\, Hungary CATEGORIES:Meetings ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2015/12/Danube-Scientific-Conference-on-Epigenetics.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20160926 DTEND;VALUE=DATE:20160927 DTSTAMP:20160426T215402Z CREATED:20160426T194422Z LAST-MODIFIED:20160426T215402Z UID:15340-1474848000-1474934399@ces.b2sg.org SUMMARY:abcam: Boston Chromatin Snapshot Series DESCRIPTION:This event will be free of charge for all attendees but early registration is required. Space is limited so early registration is recommended. Registration will close 1 September 2016.\nEpigenetics and Chromatin are playing fundamental roles in the development of organisms as well as the development of pathologies\, such as cancer. This series of meetings will aim to bring together both the scientists studying the fundamentals of chromatin and epigenetics\, and those scientists studying specific systems or diseases that chromatin dynamics could be impacting. We hope that this journal club will inspire dialog\, lots of questions\, future collaborations\, and most of all\, energetic exchange. The meeting will have at least two keynote speakers and a selection of talks from trainees (e.g.\, graduate students and postdoctoral fellows). URL:https://ces.b2sg.org/event/abcam-boston-chromatin-snapshot-series/ LOCATION:Joseph B. Martin Conference Center\, 77 Avenue Louis Pasteur\, Boston\, MA\, 02115\, United States CATEGORIES:Meetings ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/abcam1.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20160919 DTEND;VALUE=DATE:20160923 DTSTAMP:20160426T185859Z CREATED:20160426T185520Z LAST-MODIFIED:20160426T185859Z UID:15334-1474243200-1474588799@ces.b2sg.org SUMMARY:Wellcome Genome Campus: Genome Informatics conference DESCRIPTION:This 16th Genome Informatics conference will focus on large-scale approaches to understanding the structure and biology of genomes. Biology is an experimental science that is experiencing an explosion of new data. This requires biologists to increase the scale and sophistication of the information technology used for their research. \nThe conference scope encompasses a wide range of methods for the analysis of these data\, including a focus on technologies such as variant-calling\, transcriptomic analysis\, and variant interpretation\, applied to very large genomic data sets. This meeting alternates between Hinxton\, UK and Cold Spring Harbor\, New York. URL:https://ces.b2sg.org/event/wellcome-genome-campus-advanced-courses-and-scientific-conferences-genome-informatics-2016/ LOCATION:Wellcome Genome Campus\, Hinxton\, Camebridge\, United Kingdom CATEGORIES:Meetings ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/Wellcome-Genome-Campus.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20160914 DTEND;VALUE=DATE:20160917 DTSTAMP:20160426T184342Z CREATED:20160426T183029Z LAST-MODIFIED:20160426T184342Z UID:15328-1473811200-1474070399@ces.b2sg.org SUMMARY:Wellcome Genome Campus: Single Cell Genomics 2016 DESCRIPTION:Building on the success of previous single cell genomics meetings\, this year’s meeting will be held at the Wellcome Genome Campus\, Hinxton\, UK. \n\n\n\nSingle cell genomics is rapidly emerging as a revolutionary technology transforming many fields of biological research\, including immunology and cancer. Through its many applications (e.g. single cell genome sequencing\, single cell transcriptomics\, and various single cell epigenetic profiling approaches)\, researchers can characterize the genetic and functional properties of individual cells in their native conditions\, leading to numerous experimental and clinical opportunities. \nAs technology is developing\, many critical questions are arising: \n\nWhich technologies are going to set the standard in the field?\nHow many cells needed to be sampled? How should sampling be designed and optimized?\nHow can the behaviour of groups of hundreds or thousands of single cells be analysed and modelled?\nWhat is the importance of modelling when precise single-cell-states are available?\nHow can single cell genomics and epigenomics be integrated?\nWhat are the immediate implications for immunology\, cancer research and germ cells?\n\nThese questions will be the focus of discussions at this year’s meeting. This conference will bring together biologists\,  methods developers\, computational modellers and genomics researchers interested in understanding biological variation at the single cell level. URL:https://ces.b2sg.org/event/wellcome-genome-campus-single-cell-genomics-2016/ LOCATION:Wellcome Genome Campus\, Hinxton\, Camebridge\, United Kingdom CATEGORIES:Meetings ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/Wellcome-Genome-Campus.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20160913 DTEND;VALUE=DATE:20160918 DTSTAMP:20160105T222345Z CREATED:20151230T051245Z LAST-MODIFIED:20160105T222345Z UID:12204-1473724800-1474156799@ces.b2sg.org SUMMARY:Epigenetics and Chromatin DESCRIPTION:You are cordially invited to participate in the third Cold Spring Harbor Laboratory meeting on Epigenetics & Chromatin. The opening session will begin at 7:30 pm on Tuesday\, September 13 and the meeting will end after lunch on Saturday\, September 17\, 2016. As currently planned\, the program will have eight sessions devoted to oral presentations\, together with three poster sessions for presentations which cannot be accommodated in the formal sessions. Selection of talks for the oral sessions will be made by the organizers in conjunction with the session chairpersons\, from the submitted abstracts. URL:https://ces.b2sg.org/event/epigenetics-and-chromatin/ LOCATION:Unnamed Venue\, Cold Spring Harbor\, NY\, United States CATEGORIES:Meetings ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2015/12/CSH.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20160908 DTEND;VALUE=DATE:20160910 DTSTAMP:20160807T150339Z CREATED:20160625T122255Z LAST-MODIFIED:20160807T150339Z UID:16199-1473292800-1473465599@ces.b2sg.org SUMMARY:2nd Annual Epigenetics Discovery Congress DESCRIPTION:The 2nd Annual Epigenetics Discovery Congress taking place on 8-9 September\, 2016 in London – UK will gather researchers\, academics and industry professionals working in epigenetic research to avail an opportunity to explore the potential of epigenetics. The congress will contribute towards novel and existing therapeutics\, current progress and trends in the inclusion of epigenetics in drug discovery and development. \nThe Cancer Epigenetics Society is a Supporting Association for this meeting\, and our members are eligible for a 40% discount on registration fees. Please contact the Cancer Epigenetics Society at info@ces.b2sg.org to claim the discount. URL:https://ces.b2sg.org/event/2nd-annual-epigenetics-discovery-congress/ LOCATION:London Heathrow Marriot Hotel\, Bath Road \, Heathrow Airport Hayes\, UB3 5AN\, United Kingdom CATEGORIES:Meetings ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2016/06/Epi_2016.jpg ORGANIZER;CN="MnM Conferences":MAILTO:ajay.nimbalkar@mnmconferences.com END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20160908 DTEND;VALUE=DATE:20160910 DTSTAMP:20160426T194524Z CREATED:20160426T182437Z LAST-MODIFIED:20160426T194524Z UID:15324-1473292800-1473465599@ces.b2sg.org SUMMARY:abcam: RNA modifications and epitranscriptomics conference DESCRIPTION:The meeting is aimed at bringing in students and postdocs as well as faculty involved in RNA modification and epitranscriptome research.  In addition to talks\, there will be a poster session and reception.\n \n\n\n\n\n\n\n\n\n\n\n\n\nTopics \n\nM6A mRNA methylation\nBiological functions of m6A RNA methylation\nDynamic RNA modifications\n​ URL:https://ces.b2sg.org/event/abcam-rna-modifications-and-epitranscriptomics-conference/ LOCATION:University of Chicago\, 5801 S Ellis Ave\, Chicago\, IL\, 60637\, United States CATEGORIES:Meetings ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/abcam1.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20160827 DTEND;VALUE=DATE:20160831 DTSTAMP:20160802T022230Z CREATED:20160426T181215Z LAST-MODIFIED:20160802T022230Z UID:15320-1472256000-1472601599@ces.b2sg.org SUMMARY:EMBL Conference: Transcription and Chromatin DESCRIPTION:The EMBL Transcription and Chromatin meeting has a long-standing tradition in shaping the field of transcriptional regulation. The meeting brings together leading experts covering all aspects of transcription from cis-regulatory function\, long range regulation\, 3-dimensional looping\, the basal transcriptional machinery\, RNA polymerase regulation and function\, nucleosome positioning\, chromatin modifications\, chromatin remodelling\, and epigenetic inheritance of transcriptional silencing. The meeting contains many talks selected from the abstracts that are interspersed with invited speakers\, discussing the latest breakthroughs in transcriptional regulation. \n\n\n\n\n\n\nAims\nThe conference is designed to promote interactive discussions at both the talks and poster sessions. Given the excellent line up of speakers and the meeting’s outstanding reputation\, this is a ‘must’ attend for anyone interested in cutting edge research in transcription. \nTopics\n\nActivators\, enhancer function\, evolution and modelling\nLong range transcriptional regulation and enhancers\nGeneral basal transcriptional machinery\nPol II function\, pausing and the role of RNA in transcription\nChromatin modifications and transcription\nTranscriptional regulation during cell fate decisions – stem cell reprogramming and normal embryonic development URL:https://ces.b2sg.org/event/embl-conference-transcription-and-chromatin/ LOCATION:EMBL\, Heidelberg\, Germany CATEGORIES:Meetings ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/EMBL-logo--e1525286945880.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20160710 DTEND;VALUE=DATE:20160716 DTSTAMP:20160625T123423Z CREATED:20160426T174955Z LAST-MODIFIED:20160625T123423Z UID:15318-1468108800-1468627199@ces.b2sg.org SUMMARY:FASEB: Dynamic DNA Structures in Biology DESCRIPTION:For decades after its discovery\, genomic DNA was believed to exist only as a right-handed\, double helix known as B-DNA.  Its sole functions were to serve as a template for RNA synthesis or as a template for the production of identical duplexes during chromosome replication.  These core beliefs were shaken by the discovery that DNA is covalently modified and packaged into chromatin\, and that the molecule can form an enormous variety of non-B alternative structures\, including cruciforms\, a left-handed helix\, three- and four-stranded helices\, and slip-strand configurations.  Transient denaturation of the duplex during all major DNA transactions (replication\, transcription\, repair and recombination) requires chromatin modifications and promotes dynamic transitions to non-B DNA structures.  Furthermore\, repetitive DNA sequences\, which are highly over-represented in genomic DNA\, are particularly prone to structural transitions.  Studies conducted in many labs worldwide have confirmed that structural transitions are not only central to normal functions of the genome\, but also are responsible for occasional malfunctioning that leads to a disease state.  The most striking example is expansion of structure-prone DNA repeats\, which is responsible for more than thirty hereditary neurological and developmental diseases. \n\n\n\n\n\n\n\n\n\nThis SRC is the fourth meeting on Dynamic DNA Structures in Biology\, a highly interactive meeting that brings together a diverse\, international community of researchers who maintain a “DNA-centric” view of basic biological processes.  Attendees will include those interested in disease-causing repeat expansions\, chromatin dynamics\, chromosome fragility related to transcription and replication\, and the biological roles of unusual\, non-B DNA structures.  Morning and evening scientific sessions will feature established and new investigators\, and ample time for discussion will be incorporated into the program.  In addition\, short talks chosen from submitted abstracts will be included in session\, with preference given to trainees.  Afternoon poster sessions will further foster the exchange of ideas and facilitate the establishment of new collaborations.  It is anticipated that funds will be available to support the attendance of young investigators and trainees. URL:https://ces.b2sg.org/event/faseb-dynamic-dna-structures-in-biology/ LOCATION:Horowitz Performing Arts Hall and Nita Choukas Theater\, Long Walk 10\, Saxtons River\, VT\, United States CATEGORIES:Meetings ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2015/12/FASEB.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20160710 DTEND;VALUE=DATE:20160714 DTSTAMP:20160625T123308Z CREATED:20160426T171857Z LAST-MODIFIED:20160625T123308Z UID:15310-1468108800-1468454399@ces.b2sg.org SUMMARY:21st INTERNATIONAL CHROMOSOME CONFERENCE DESCRIPTION:It is a great pleasure to announce that the 21st International Chromosome Conference edition will take place in Foz do Iguaçu\, Brazil\, on July 10-13\, 2016. This will be the first time that the ICC will be held in South America. Foz do Iguaçu (Foz)\, is a desirable location in Brazil due to its beautiful nature\, human cultural diversity\, and easy access to several South American countries. Foz ICC 2016 is an excellent opportunity to bring exciting chromosome related topics and new technologies together for discussion under the view of the most outstanding chromosome biologists. \n  URL:https://ces.b2sg.org/event/21st-international-chromosome-conference/ LOCATION:Rafain Palace Hotel & Convention Center\, Foz do Iguaçu\, Brazil CATEGORIES:Meetings ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/ICC.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20160626 DTEND;VALUE=DATE:20160629 DTSTAMP:20160426T173907Z CREATED:20160426T173006Z LAST-MODIFIED:20160426T173907Z UID:15314-1466899200-1467158399@ces.b2sg.org SUMMARY:Cell Symposium: Transcriptional Regulation in Development and Disease DESCRIPTION:Transcriptional Regulation in Development and Disease will bring together researchers studying developmental biology and its disruption in disease with those examining the specific molecular and cellular mechanisms of transcriptional regulation.\n \n\n\n\nIn addition to the presentations from the invited speakers\, we are also eagerly anticipating hearing from you about emerging exciting discoveries that can be considered for presentation at the meeting in the form of short talks or posters on topics including: \n\nDevelopmental dynamics\nTranscriptional memory and plasticity\nNon-coding RNAs and retroelements\nChromatin structure and epigenetics\nStem cells and developing systems\nTools and techniques for in vivo analysis\n\nWe also hope you will take advantage of the chance to hear from Cell Press editors during our Author Workshop. This informal Q&A session is a great chance to get an editorial perspective on effectively communicating about your research. URL:https://ces.b2sg.org/event/cell-symposium-transcriptional-regulation-in-development-and-disease/ LOCATION:Unnamed Venue\, Chicago\, IL\, United States CATEGORIES:Meetings ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/Cell-Symposium.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20160619 DTEND;VALUE=DATE:20160625 DTSTAMP:20160419T161448Z CREATED:20151230T050829Z LAST-MODIFIED:20160419T161448Z UID:12201-1466294400-1466812799@ces.b2sg.org SUMMARY:FASEB meeting: Biological Methylation\, Fundamental Mechanisms in Health and Disease DESCRIPTION:Conference Summary\nThis SRC is focused on  the role of Methylation Dynamics in nuclear and cytoplasmic biological processes and how this modification impacts development\, epigenetic cellular identity\, tissue homeostasis and disease. Studies looking at how this chemical modification impacts nucleic acid and protein function across model systems and in disease models will be presented. These topics will be complemented with presentations on how methylation states are established\, maintained\, interpreted and inter-converted\, along with their functional cellular consequences  and how this translates into developmental and disease states. Since methylation has become a major therapeutic target in recent years\, there will be a focus on the advancements in therapeutics and technologies used to quantitatively monitor this modification in cells and organisms. \nThis meeting will bring together an interdisciplinary group of scientists interested in how a small covalent modification can have such profound biological impact.  Invited speakers are experts in biological methylation from a variety of perspectives including cell and developmental biology\, molecular biology\, epigenetics/epigenomics\,  structural biology and chemical biology.  The conference will be structured to optimize interactions among all attendees\, with several poster sessions and technology workshops. A significant number of oral presentations will be chosen from poster abstracts submitted by trainees and junior faculty.  This conference will also be an excellent opportunity for scientists less familiar with methylation mediated signaling and epigenetics to learn how this rapidly evolving field could impact their research. URL:https://ces.b2sg.org/event/biological-methylation-fundamental-mechanism-in-health-and-disease/ LOCATION:Lisbon Marriott Hotel\, Avenida dos Combatentes \, Lisboa (Lisbon) 1600-042 Portugal\, Lisbon\, Portugal CATEGORIES:Meetings ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2015/12/FASEB.png END:VEVENT END:VCALENDAR